Erratum: Disulfiram combined with chemoimmunotherapy potentiates pancreatic cancer treatment efficacy through the activation of cGAS-STING signaling pathway via suppressing PARP1 expression.
[This corrects the article on p. 2055 in vol. 13, PMID: 37293156.].